DandiBioscience, Inc. (XKON:A343090) announced that it will issue series 2 unregistered coupon nonguaranteed private convertible bond for gross proceeds of KRW 1,300,000,000 on April 16, 2021. The bonds will be issued at par. The transaction will include participation from Seok-Woo Lee, Chang-seung Lee, Seokmyeon Lee, Oh-soon Shin, Byeong-ho Heo, Gyubeom Jung, Yeo-tak Yoon, Yeo-jik Yoon, Jaeyoung Jang, and Dong-jun Kim. The bonds are zero coupon bonds with a yield to maturity of 4% per annum. The bonds will mature on April 22, 2024. The bonds are convertible into 206,414 common shares of the company at a fixed conversion price of KRW 6,298 per share from April 22, 2022 to March 22, 2024. The date of subscription is April 20, 2021 and expected date of payment is April 22, 2021. The transaction is approved by the board of directors of the company. The bonds are subject to prohibition of conversion and division of rights for one year from the date of issue of bonds.